Izidor Kern

1.9k total citations
62 papers, 1.2k citations indexed

About

Izidor Kern is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Physiology. According to data from OpenAlex, Izidor Kern has authored 62 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 21 papers in Oncology and 15 papers in Physiology. Recurrent topics in Izidor Kern's work include Lung Cancer Diagnosis and Treatment (10 papers), Asthma and respiratory diseases (10 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers). Izidor Kern is often cited by papers focused on Lung Cancer Diagnosis and Treatment (10 papers), Asthma and respiratory diseases (10 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers). Izidor Kern collaborates with scholars based in Slovenia, Italy and Austria. Izidor Kern's co-authors include Peter Korošec, Mitja Košnik, Nadja Triller, Tanja Čufer, Matjaž Fležar, Fiorella Calabrese, Federica Pezzuto, Francesca Lunardi, Paul Hofman and Matija Rijavec and has published in prestigious journals such as Scientific Reports, CHEST Journal and Annals of Oncology.

In The Last Decade

Izidor Kern

59 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Izidor Kern Slovenia 18 531 360 248 181 176 62 1.2k
Oliver J. McElvaney Ireland 18 537 1.0× 161 0.4× 288 1.2× 249 1.4× 145 0.8× 41 1.2k
Chul Hwan Kim South Korea 22 462 0.9× 379 1.1× 313 1.3× 95 0.5× 92 0.5× 109 1.4k
Gen Yamada Japan 20 644 1.2× 194 0.5× 317 1.3× 123 0.7× 117 0.7× 96 1.3k
D. Maroeska W. M. te Loo Netherlands 22 178 0.3× 219 0.6× 297 1.2× 310 1.7× 278 1.6× 73 1.5k
Anna Napoli Italy 16 299 0.6× 207 0.6× 373 1.5× 125 0.7× 135 0.8× 44 1.0k
Yubiao Guo China 16 401 0.8× 90 0.3× 295 1.2× 225 1.2× 92 0.5× 70 1.1k
Stephen M. Lagana United States 22 500 0.9× 289 0.8× 714 2.9× 79 0.4× 344 2.0× 71 2.1k
Eleni Karapanagiotou United Kingdom 21 288 0.5× 591 1.6× 460 1.9× 112 0.6× 194 1.1× 68 1.4k
Edy Y. Kim United States 17 256 0.5× 170 0.5× 304 1.2× 761 4.2× 149 0.8× 40 1.5k
Masaki Hashimoto Japan 17 670 1.3× 447 1.2× 315 1.3× 79 0.4× 50 0.3× 117 1.5k

Countries citing papers authored by Izidor Kern

Since Specialization
Citations

This map shows the geographic impact of Izidor Kern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Izidor Kern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Izidor Kern more than expected).

Fields of papers citing papers by Izidor Kern

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Izidor Kern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Izidor Kern. The network helps show where Izidor Kern may publish in the future.

Co-authorship network of co-authors of Izidor Kern

This figure shows the co-authorship network connecting the top 25 collaborators of Izidor Kern. A scholar is included among the top collaborators of Izidor Kern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Izidor Kern. Izidor Kern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cooper, Wendy A., Fleur Webster, Kelly J. Butnor, et al.. (2024). Data set for the reporting of lung cancer: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology. 86(5). 665–680.
2.
Fortarezza, Francesco, Federica Pezzuto, Paul Hofman, et al.. (2022). COVID-19 Pulmonary Pathology: The Experience of European Pulmonary Pathologists throughout the First Two Waves of the Pandemic. Diagnostics. 12(1). 95–95. 2 indexed citations
3.
Čufer, Tanja, et al.. (2022). Real-life long-term outcomes of upfront surgery in patients with resectable stage I-IIIA non-small cell lung cancer. Radiology and Oncology. 56(3). 346–354. 8 indexed citations
4.
Metović, Jasna, Fabrizio Bianchi, Paul Hofman, et al.. (2021). Morphologic and molecular classification of lung neuroendocrine neoplasms. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 478(1). 5–19. 45 indexed citations
5.
Vrankar, Martina, et al.. (2020). Prognostic value of PD-L1 expression in patients with unresectable stage III non-small cell lung cancer treated with chemoradiotherapy. Radiation Oncology. 15(1). 247–247. 22 indexed citations
6.
Kern, Izidor, et al.. (2019). Idiopathic pulmonary fibrosis in patients with early-stage non-small-cell lung cancer after surgical resection. Radiology and Oncology. 53(3). 357–361. 6 indexed citations
7.
Rijavec, Matija, Mira Šilar, Ana Koren, et al.. (2019). Transcription factors gene expression in chronic rhinosinusitis with and without nasal polyps. Radiology and Oncology. 53(3). 323–330. 4 indexed citations
8.
Filipović, Milica Kovačević, et al.. (2019). P2.09-30 PD-L1 Testing and Clinical Benefit in Patients Treated with CPI. Journal of Thoracic Oncology. 14(10). S781–S782. 1 indexed citations
9.
Škrgat, Sabina, Izidor Kern, Mira Šilar, et al.. (2018). Systemic and airway oxidative stress in competitive swimmers. Respiratory Medicine. 137. 129–133. 10 indexed citations
10.
Pasello, Giulia, Giulia Zago, Francesca Lunardi, et al.. (2018). Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical–pathological features and intratumor heterogeneity over time. Annals of Oncology. 29(5). 1258–1265. 72 indexed citations
11.
Filipović, Milica Kovačević, et al.. (2017). PD-L1 in NSCLC cytology. Annals of Oncology. 28. ii1–ii2. 4 indexed citations
12.
Kovač, Viljem, Matjaž Zwitter, Danijela Štrbac, et al.. (2017). P3.03-030 Cisplatin with Pemetrexed or Gemcitabine in Prolonged Infusion for Inoperable Mesothelioma: A Phase II Randomized Trial. Journal of Thoracic Oncology. 12(1). S1362–S1363. 2 indexed citations
13.
Koren, Ana, et al.. (2015). BMI1, ALDH1A1, and CD133 Transcripts Connect Epithelial‐Mesenchymal Transition to Cancer Stem Cells in Lung Carcinoma. Stem Cells International. 2016(1). 9714315–9714315. 43 indexed citations
14.
Kern, Izidor, et al.. (2012). Impact of ERCC1 expression on treatment outcome in small-cell lung cancer patients treated with platinum-based chemotherapy. European Journal of Cancer. 48(18). 3378–3385. 15 indexed citations
15.
Rijavec, Matija, Mira Šilar, Nadja Triller, et al.. (2011). Expressions of Topoisomerase IIα and BCRP in Metastatic Cells are Associated with Overall Survival in Small Cell Lung Cancer Patients. Pathology & Oncology Research. 17(3). 691–696. 13 indexed citations
16.
Zwitter, Matjaž, et al.. (2007). Metastatic Adenocarcinoma of the Lung in a 27-Year-Old Pregnant Woman. Journal of Thoracic Oncology. 2(5). 450–452. 4 indexed citations
17.
Kern, Izidor, et al.. (2003). Multinucleated Giant Cells in Bronchoalveolar Lavage. Acta Cytologica. 47(3). 426–430. 9 indexed citations
18.
Kern, Izidor, et al.. (2002). Invasive Pulmonary Aspergillosis. Respiration. 69(6). 521–525. 17 indexed citations
19.
Tomič, Viktorija & Izidor Kern. (1999). Bacillus cereus pneumonia with empyema. Clinical Microbiology and Infection. 5(11). 713–714. 2 indexed citations
20.
Kern, Izidor, et al.. (1998). The effect of latent adenovirus 5 infection on cigarette smoke-induced lung inflammation. European Respiratory Journal. 11(3). 664–669. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oliver J. McElvaney Breakdown of academic impact, for papers by Chul Hwan Kim Breakdown of academic impact, for papers by Gen Yamada Breakdown of academic impact, for papers by D. Maroeska W. M. te Loo Breakdown of academic impact, for papers by Anna Napoli Breakdown of academic impact, for papers by Yubiao Guo Breakdown of academic impact, for papers by Stephen M. Lagana Breakdown of academic impact, for papers by Eleni Karapanagiotou Breakdown of academic impact, for papers by Edy Y. Kim Breakdown of academic impact, for papers by Masaki Hashimoto
Rankless by CCL
2026